Results 21 to 30 of about 41,043 (214)
Human Vaccines & Immunotherapeutics, 2023 Introduction of primary COVID-19 vaccination has helped reduce severe disease and death caused by SARS-CoV-2 infection. Understanding the protection conferred by heterologous booster regimens informs alternative vaccination strategies that enable ...
Moe H. Kyaw +4 more
doaj +1 more source
SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA Vaccination
Vaccines, 2023 Since the emergence of SARS-CoV-2, maintaining healthcare worker (HCW) health and safety has been fundamental to responding to the global pandemic. Vaccination with mRNA-base vaccines targeting SARS-CoV-2 spike protein has emerged as a key strategy in ...
Kevin D. Dieckhaus +10 more
doaj +1 more source
Effectiveness of Comirnaty® Vaccine and Correlates of Immunogenicity and Adverse Reactions: A Single-Center Prospective Case Series Study [PDF]
, 2022 The literature suggests that real-world data on the effectiveness and safety of the BNT162b2 vaccine depend on the characteristics of the vaccinated volunteers.
Fernández-Lázaro, Diego +7 more
core +2 more sources
Médecine et Maladies Infectieuses Formation, 2022 INTRODUCTION: Le risque de thrombocytopénies thrombotiques immunitaires induites par le vaccin ChAdOx1-nCoV19 a conduit la France à recommander une seconde dose par un vaccin ARNm chez les personnes
Lachâtre, M. +9 more
openaire +1 more source
Cellular Immune Response Induced by mRNA Vaccines Against SARS-CoV-2. [PDF]
Immun Inflamm DisSARS‐CoV‐2 vaccine induces cellular immune response. T‐cells play a protective role for COVID‐19. ABSTRACT The disease caused by SARS‐CoV‐2 is known as COVID‐19, and it can range from mild symptoms to severe clinical manifestations, including respiratory failure, pneumonia, and organ failure. Since its emergence in 2019, more than 7 million deaths have
Tovar V +4 more
europepmc +2 more sources
Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination [PDF]
Vaccines, 2021 Anaphylactic reactions were observed after Singapore’s national coronavirus disease 2019 (COVID-19) vaccination programme started in December 2020. We report the clinical and laboratory features of three patients in our institution who developed anaphylactic reactions after receiving the Pifzer BNT162b2 vaccine.
Xin Rong Lim +14 more
openaire +3 more sources
Granulomatous anterior uveitis following mRNA-based COVID-19 vaccination: A case report
Indian Journal of Ophthalmology, 2023 A 23-year-old patient presented with complaints of redness, pain, photophobia, and blurred vision in the right eye 15 days after she received the third dose of BNT162b2 vaccination.
Furkan Cam, Gizem Gok, Hande Celiker
doaj +1 more source
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants [PDF]
, 2022 Vaccination shows efficacy in protecting from COVID-19, but regime and dosing optimization is still ongoing. Here the authors show that BNT162b2, mRNA-1273, or their combination with ChAdOx1 induces similar antibody responses, and those receiving three ...
Belik, Milja +24 more
core +1 more source
Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination
Journal of Korean Medical Science, 2022 Dermatomyositis (DM) is one of the uncommon multi-organ idiopathic inflammatory myopathies that has been reported following the hepatitis B, Influenza, tetanus toxoid, H1N1, and BCG vaccines. However, an association with the coronavirus disease 2019 (COVID-19) vaccine is yet to be reported.
Wesam Gouda +5 more
openaire +2 more sources
International Journal of Occupational Medicine and Environmental Health, 2022 Objectives The study aimed to analyze the effect of BNT162b2 vaccination among Polish healthcare workers in terms of serologic response and adverse events.
Bartosz Siewert +9 more
doaj +1 more source